End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
46.16 CNY | -0.04% | +10.27% | +2.06% |
Apr. 26 | Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3% | MT |
Apr. 17 | Jiangsu Hengrui Medicine Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.06% | 40.55B | |
+26.10% | 681B | |
+21.24% | 556B | |
-5.38% | 361B | |
+16.80% | 325B | |
+4.64% | 285B | |
+13.53% | 235B | |
+3.81% | 199B | |
-11.74% | 189B | |
-4.01% | 157B |
- Stock Market
- Equities
- 600276 Stock
- News Jiangsu Hengrui Medicine Co., Ltd.
- Nomura Adjusts Jiangsu Hengrui Medicine's Price Target to 50.19 Yuan From 46.30 Yuan, Keeps at Neutral